OnKure Therapeutics
USEntry
2023
Hold
1yr
Exit
2024
Who owns OnKure Therapeutics?
OnKure Therapeutics was owned by Abingworth through Abingworth Bioventures 8 (2021 vintage) from 2023 to 2024, exited via IPO.
Buyer identity available on Pro.
Hand-verified · updated 2026-06-10
Exit Type
IPO
Buyer
MOIC
–
Exit Year
2024
More from Abingworth Bioventures 8
Other portfolio companies in the same fund.
UK
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
FranceTrack OnKure Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy OnKure Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on OnKure Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue